Phase 3 Proliferative Diabetic Retinopathy Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
Non-Proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc.930 enrolled1 locationNCT07235085
Recruiting
Phase 3
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Proliferative Diabetic Retinopathy (PDR)
Jaeb Center for Health Research426 enrolled20 locationsNCT06790784
Recruiting
Phase 3
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd360 enrolled30 locationsNCT06817265
Recruiting
Phase 3
Efficacy of intravitreal triamcinolone acetonide before pan retinal photocoagulation for improvement of visual acuity and macular edema in diabetic retinopathy
Diabetic macular edema in severe non proliferative diabetic retinopathy (NPDR)or proliferative diabetic retinopathy(PDR)
Eye Research Center, Farabi Eye Hospital60 enrolled1 locationACTRN12607000225415